# JPM (JPMorgan Chase & Co.) Stock Analysis — 2026-10-14

> JPMorgan Chase remains the best-run U.S. money-center bank by almost every operating metric — 20% ROTCE, 17% ROE, 13.9% CET1, $5.0T balance sheet, $2.71T deposits and #1 IB fee share at 8.4% — and Q3 2026 grew managed revenue 8% YoY to $50.9B with net income of $15.3B (+6% YoY). Yet the quarter was ...

- Verdict: **Hold**
- Price at analysis: $331.43
- 1Y price target: $340.00 (+2.6% implied)
- 3Y price target: $395.00 (+19.2% implied)
- Technicals: RSI 37, MACD bearish
- Source: https://stockquantai.com/research/jpm/2026-10-14

## Executive Summary

JPMorgan Chase remains the best-run U.S. money-center bank by almost every operating metric — 20% ROTCE, 17% ROE, 13.9% CET1, $5.0T balance sheet, $2.71T deposits and #1 IB fee share at 8.4% — and Q3 2026 grew managed revenue 8% YoY to $50.9B with net income of $15.3B (+6% YoY). Yet the quarter was a rare miss: GAAP EPS $5.57 ($5.75 ex-significant item) vs $5.90-$5.94 consensus and revenue $50.17-$50.9B vs $51.3-$51.97B expected, driven by softer fixed-income/IB, a 12% surge in expenses to $27.3B outpacing revenue, and a pullback in buybacks that management framed as capital caution. Morningstar's response — raising fair value to $330 and rating 3-stars — captures the tension: a wide-moat compounder that is now fairly valued after a run to $366.50. With the stock at $331.43, down 9.6% from highs and 6% in the last month on high Treasury yields and macro uncertainty, risk/reward looks balanced. NII strength (+13% YoY to $27.1B, FY guide raised to ~$105.5B) and fortress capital/dividend growth offset margin pressure and capital-markets cyclicality, supporting a Neutral stance with modest upside to fair value plus dividends.

## Price Targets

| Horizon | Price | Implied Growth |
|---|---|---|
| 1 Year | $340.00 | +2.6% |
| 3 Year | $395.00 | +19.2% |

## Scenarios

| Scenario | 1Y Price | 3Y Price | Thesis |
|---|---|---|---|
| Hyper Bull | $420.00 | $520.00 | NII beats $110B+, IB supercycle returns with double-digit fee growth, expenses controlled for positive leverage, ROTCE sustains 22-23%. Multiple re-rates to 16-17x on quality premium plus aggressive buybacks resume. Requires soft landing, rate cuts without recession, and benign credit. |
| Bull | $375.00 | $440.00 | Durable NII, resilient credit with lower provisions, and CIB recovery drive mid-teens EPS growth. 13x forward proves cheap for 20% ROTCE compounder; dividend + buybacks drive 13%+ 1Y total return and new highs above $366.50. |
| Neutral | $340.00 | $395.00 | Fairly valued wide-moat bank grows earnings high-single digits but expense growth and choppy capital markets cap multiple expansion. Stock tracks fair value ~$330-$340 plus dividend, compounding to ~$395 in 3 years on retained earnings and modest buybacks. |
| Bear | $295.00 | $280.00 | Margin pressure persists as 12% expense growth outruns NII, IB/FICC stays soft, and buyback restraint continues. Credit normalization accelerates provisions, ROTCE fades to mid-teens, multiple compresses to 11-12x. Down ~11% in 1Y with underperformance vs peers. |
| Hyper Bear | $240.00 | $200.00 | Hard landing/recession: loan losses spike, deposits reprice, NII falls, markets revenue collapses, capital build halts distributions. Fortress prevents failure but earnings fall 30%+, multiple to 9-10x trough, down ~28% in 1Y with multi-year repair. |

## Key Metrics

- Market Cap: $888.63B
- P/E Ratio: ~15.0x TTM (~13x forward)
- P/S Ratio: ~4.4x (est.)
- Revenue: $50.9B Q3 managed (+8% YoY)
- Net Income: $15.3B Q3 (+6% YoY)
- EPS: $5.57 GAAP ($5.75 ex-item) vs $5.90-$5.94 est.
- Dividend Yield: ~1.8% (10% hike, 27% payout)
- Beta: 1.10 (est.)
- 52-Week High: $366.50
- 52-Week Low: $279.10
- Short Interest: N/A (no elevated short data reported)

## Micro Analysis

Operating excellence intact but Q3 revealed margin and capital-allocation friction: revenue growth more than offset by expense growth and a miss on both lines.

- **Q3 miss despite YoY growth**: Q3 managed revenue $50.9B (+8% YoY, +6.5% to $50.17B on reported basis) and diluted EPS $5.57 (+9.9-10% YoY from $5.07) both missed consensus ($5.90-$5.94 EPS, $51.3-$51.97B revenue). CIB softened markedly vs strong Q2, with lower fixed-income markets only partly offset by equities revenue +49% to $22.7B CIB revenue and higher deposits/wholesale loans.
- **Industry-leading profitability with deteriorating efficiency**: ROE 17%, ROTCE 20% (23% cited pre-Q3) remains best-in-class vs peers. However noninterest expense $27.3B +12% YoY on volume-related costs and front-office investment outpaced 8% revenue growth, deteriorating overhead ratio. Management raised both NII guidance and expense forecast, implying net margin pressure ahead.
- **Fortress balance sheet and shareholder return shift**: CET1 Standardized 13.9%, Advanced 14.1%, $303B total capital, $5.0T assets, $2.71T deposits, $7.6T client assets in AWM. Dividend raised 10% with 15-16 year consecutive growth, 27% payout ratio. Offsetting positive: Dimon cut buyback pace despite $50B authorization — the 'bigger story' signaling valuation discipline and capital caution ahead of Basel/credit normalization.
- **Franchise scale and diversification**: Three segments (CCB with 5,000+ US branches, CIB with 8.4% IB fee share ranked #1 globally, AWM) plus money-market ETF (JMMF) benefit. Each line of business grew in Q3. Scale supports durable NII ($27.04-$27.1B in Q3, +13% YoY) driven by deposit franchise and balance-sheet strength, not just rates.
- **Valuation at fair value**: At $888.63B market cap (~15x TTM ~$22 EPS, ~13x forward P/E per bulls, ~4.4x sales), stock trades essentially at Morningstar fair value $330 (3-star, Wide Moat, Medium Uncertainty). Wall Street Moderate Buy with 14% upside target is historically bullish-skewed and already dented by 6%+ pullback and YTD only +3.3%.

## Macro Analysis

Higher-for-longer rates help NII but hurt capital markets, credit costs, and multiples; Dimon warnings on hikes and economy frame balanced macro.

- **Higher rates + high Treasury yields: double-edged**: Net interest income +13% YoY and FY guide to $105.5B (+2.3% sequential for large banks expected) supported by higher deposit/loan balances. Conversely, multidecade-high bond yields weighed sentiment, drove 6%+ pullback, pressured IB/debt underwriting and equity multiples.
- **Capital markets softening after hot start**: Scorching H1 capital markets cooled in Q3; JPM CIB softened markedly from Q2 robust pace. Trading strength (equities +49%) offset weaker FICC/IB, but volatility in markets revenue makes forward earnings less predictable.
- **U.S. economy solid but CEO cautious**: Management described U.S. economy as solid, small-business optimism dipped in September. Dimon warned of risks from further rate hikes, inflation clouding outlook, and underlying economic concerns — consistent with building capital (13.9% CET1) rather than maximizing buybacks.
- **Credit normalization manageable so far**: Provisions lower with improved card charge-off outlook cited by bulls, reflecting resilient consumer. Risk is lagged effect of higher rates on wholesale/commercial and consumer delinquencies if labor weakens; strong reserves provide buffer but limit operating leverage.
- **Bank earnings tape mixed**: Oct 13 bank earnings drove mixed trading with chip pressure; JPM slid 3.8% premarket then finished flat to +1% near $338 intraday before closing $331.43 on 13.76M volume below VWAP $335. Shows market indecisive on beats vs misses across large-caps.

## Revenue Opportunities

- **NII durability from deposit franchise** (potential: high): Higher deposit and wholesale loan balances drove 13% NII growth; raised FY NII outlook to ~$105.5B. $2.71T deposits and 5,000-branch network provide low-cost funding advantage even if Fed pauses.
- **CIB rebound and #1 IB share** (potential: medium): 8.4% global IB fee share leaves JPM best positioned for M&A/DCM/ECM recovery. Equities trading record (+49%) shows ability to monetize volatility; any capital-markets re-acceleration drops high-margin fees.
- **Asset & Wealth Management scaling** (potential: medium): $7.6T client assets plus money-market ETF demand (JMMF) amid high cash yields drive recurring fee income, less capital-intensive than lending and supports ROTCE expansion.

## Headwinds

- **Expense creep and efficiency erosion** (severity: high): Expenses +12% YoY vs revenue +8%; management raised expense guide alongside NII guide. Volume-related costs, compensation, and tech/front-office investment suggest structural cost pressure limiting positive operating leverage.
- **Buyback pullback signals capital/valuation cap** (severity: medium): Despite $50B authorization and $303B capital, Dimon slowed repurchases. Implies stock not cheap at 13-15x earnings, regulatory (Basel) buffer needs, or caution on credit — removes key EPS support that powered prior outperformance.
- **Capital-markets cyclicality and rate/inflation risk** (severity: medium): Q3 FICC/IB softness shows dependence on markets; further rate hikes or sticky inflation could invert benefit (higher credit costs, lower loan growth, lower multiples). CEO explicitly flagged these risks.

## Tailwinds

- **Best-in-class profitability and moat** (strength: high): 20% ROTCE, 17% ROE, Wide Moat rating, global scale in 66 countries with 320,560 employees. Allows premium multiple vs peers and resilience through cycles.
- **Fortress capital + dividend compounder** (strength: medium): 13.9% CET1, 27% payout, 10% dividend hike, 15-16 years growth, $50B repurchase capacity. Supports total return even when price flat; dividend safety high.
- **Oversold technical reset** (strength: medium): RSI 37.3, -9.6% off $366.50 high, -6% last month, YTD +3.3% lagging prior momentum. Washout of crowded positioning after miss creates cleaner entry vs chasing highs; Morningstar fair value $330 now acts as support.

## Disclaimer

This report was generated by an AI model and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always conduct your own research and consult a licensed financial advisor before making investment decisions.